Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 12
Merck & Vioxx At a Glance
Parties in Upcoming Vioxx Trials Seek Delays
What's Left of the FDA After Vioxx?
By Edward J. Parr Jr., Esq.
Celebrex, Bextra Complaints Filed in Wake of April 7 FDA Action
Celebrex/Vioxx Plaintiff Says Doctor Told Her to Ignore Side Effect Reports
MDL Judge Says Vioxx Remand Motions to be Dealt With As a Group
Order Disputes Statements Made in Appeals Court's Disqualification of Vioxx Judge
Merck Urges Mich. Court to Reconsider Remand Order That Was Based on Ky. Ruling
